A detailed history of Harbor Capital Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 8,964 shares of TMDX stock, worth $572,799. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,964
Previous 6,048 48.21%
Holding current value
$572,799
Previous $911,000 54.45%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$135.68 - $176.11 $395,642 - $513,536
2,916 Added 48.21%
8,964 $1.41 Million
Q2 2024

Jul 09, 2024

BUY
$72.62 - $150.62 $332,454 - $689,538
4,578 Added 311.43%
6,048 $911,000
Q1 2024

May 13, 2024

BUY
$70.86 - $89.93 $104,164 - $132,197
1,470 New
1,470 $109,000
Q2 2023

Jul 11, 2023

BUY
$66.23 - $88.73 $15,232 - $20,407
230 New
230 $19,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.